Obesity and bariatric intervention in patients with chronic renal disease

Maria Irene Bellini1, Filippo Paoletti2, Paul Elliot Herbert1,3

  • 11 Renal and Transplant Directorate, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom of Great Britain and Northern Ireland.

Insights

Obesity is linked to chronic kidney disease, but body mass index alone does not determine transplant eligibility. Focus on overall patient frailty for kidney transplant candidacy.

Area of Science:

  • Nephrology
  • Metabolic Disorders
  • Transplantation Medicine

Background:

  • Obesity is a significant risk factor for chronic metabolic conditions leading to kidney damage.
  • The relationship between obesity and chronic kidney disease (CKD) requires further investigation.

Purpose of the Study:

  • To review existing evidence on the link between obesity and CKD.
  • To explore the role of bariatric surgery in kidney transplantation for obese patients.
  • To assess the validity of body mass index (BMI) as a sole criterion for transplant eligibility.

Main Methods:

  • A comprehensive literature review was conducted.
  • Evidence regarding obesity, CKD, and kidney transplantation was analyzed.
  • The impact of bariatric surgery on transplant outcomes was examined.

Main Results:

  • No definitive evidence supports using BMI as the sole determinant for kidney transplant eligibility.
  • The obesity paradox suggests better survival in obese patients pre-transplant.
  • Bariatric surgery shows emerging promise for improving outcomes in obese transplant candidates.

Conclusions:

  • Clinicians should not rely solely on BMI for kidney transplant eligibility.
  • Comprehensive frailty assessments are crucial for evaluating transplant candidates.
  • Further research is needed on the long-term benefits of bariatric surgery for kidney transplant recipients.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
266
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
613
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.2K